Literature DB >> 28573330

Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder.

Akira Higashiyama1, Tsuyoshi Komori2, Yuki Inada2, Mitsuo Nishizawa2, Hideto Nakajima3, Yoshifumi Narumi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28573330     DOI： 10.1007/s00259-017-3735-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

Review 1.  Neuromyelitis Spectrum Disorders.

Authors:  Brian G Weinshenker; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2017-04       Impact factor: 7.616

2.  Neuromyelitis optica spectrum disorder: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography findings--case report.

Authors:  Hirofumi Oyama; Shigeru Miwa; Tomoyuki Noda; Atsuhiro Sobajima; Akira Kito; Hideki Maki; Kenichi Hattori; Kentaro Wada
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

3.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910
  3 in total
  2 in total

1.  Striking neurologic 18F-FDG PET/CT pattern in Devic's disease (neuromyelitis optica spectrum disorder).

Authors:  Diego Alfonso López-Mora; Albert Flotats; Alejandro Fernández; Marina Sizova; Valle Camacho; Ignasi Carrió
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-27       Impact factor: 9.236

Review 2.  PET imaging of reactive astrocytes in neurological disorders.

Authors:  Yu Liu; Han Jiang; Xiyi Qin; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-07       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.